Literature DB >> 22608588

Treatment of refractory intracranial hypertension with 23.4% saline in children with severe traumatic brain injury.

Kazuma Nakagawa1, Cherylee W J Chang, Matthew A Koenig, Mihae Yu, Sheri Tokumaru.   

Abstract

The safety and efficacy of osmotic therapy with mannitol and 3% saline in the pediatric head-injured population has been widely reported; the use of 23.4% saline in children for the treatment of refractory intracranial hypertension has not. The clinical and physiologic responses of multiple 23.4% saline boluses in two children with severe traumatic brain injury (TBI) are presented. No complications were associated with the use of 23.4% saline in either patient.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608588     DOI: 10.1016/j.jclinane.2011.10.011

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  4 in total

Review 1.  New trends in hyperosmolar therapy?

Authors:  Michael N Diringer
Journal:  Curr Opin Crit Care       Date:  2013-04       Impact factor: 3.687

2.  Prehospital hypertonic saline resuscitation attenuates the activation and promotes apoptosis of neutrophils in patients with severe traumatic brain injury.

Authors:  Wolfgang G Junger; Shawn G Rhind; Sandro B Rizoli; Joseph Cuschieri; Andrew J Baker; Pang N Shek; David B Hoyt; Eileen M Bulger
Journal:  Shock       Date:  2013-11       Impact factor: 3.454

Review 3.  Hyperosmolar Therapy for Severe Traumatic Brain Injury in Pediatrics: A Review of the Literature.

Authors:  Norman E Fenn; Caroline M Sierra
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Nov-Dec

4.  Locally Acquired Eastern Equine Encephalitis Virus Disease, Arkansas, USA.

Authors:  Jeremy Garlick; T Jacob Lee; Patrick Shepherd; W Matthew Linam; Daniel M Pastula; Susan Weinstein; Stephen M Schexnayder
Journal:  Emerg Infect Dis       Date:  2016-12-15       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.